Characterization of subspecies of apolipoprotein A-I-containing lipoprotein in homozygotes for familial lecithin:cholesterol acyltransferase deficiency. 1994

T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
Department of Pediatrics, Kumamoto University School of Medicine, Japan.

We characterized the two species of lipoproteins containing apolipoprotein A-I (apoA-I), one containing only apoA-I (LpA-I) and the other containing apoA-I and apoA-II (LpA-I/A-II), in four homozygotes for familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Two homozygotes lacked both LCAT mass and activity, whereas the other two had some residual LCAT mass and activity. In these patients, the amount of all apoA-I-containing lipoproteins was one fourth that of normal control subjects, and > 60% was LpA-I. The chemical composition of both LpA-I and LpA-I/A-II is characterized by markedly decreased ratios of neutral to polar lipids compared with those of normals and the sizes of LpA-I and LpA-I/A-II particles are shifted to smaller and larger diameter ranges when compared with those of normal particles. Changes in particle diameter are also reflected in slower electrophoretic mobilities of both LpA-I and LpA-I/A-II particles. All of these abnormalities were more evident in the two homozygotes who lacked LCAT activity. Incubation of LCAT-deficient plasma with LCAT markedly corrected the chemical and physical abnormalities in both LpA-I and LpA-I/A-II particles. These data, taken together, emphasize the importance of LCAT in modifying the chemical composition, size, and shape of LpA-I and LpA-I/A-II particles.

UI MeSH Term Description Entries
D007862 Phosphatidylcholine-Sterol O-Acyltransferase An enzyme secreted from the liver into the plasma of many mammalian species. It catalyzes the esterification of the hydroxyl group of lipoprotein cholesterol by the transfer of a fatty acid from the C-2 position of lecithin. In familial lecithin:cholesterol acyltransferase deficiency disease, the absence of the enzyme results in an excess of unesterified cholesterol in plasma. Lecithin Cholesterol Acyltransferase,Cholesterol Ester Lysolecithin Acyltransferase,Lecithin Acyltransferase,Phosophatidylcholine-Sterol Acyltransferase,Acyltransferase, Lecithin,Acyltransferase, Lecithin Cholesterol,Acyltransferase, Phosophatidylcholine-Sterol,Cholesterol Acyltransferase, Lecithin,O-Acyltransferase, Phosphatidylcholine-Sterol,Phosophatidylcholine Sterol Acyltransferase,Phosphatidylcholine Sterol O Acyltransferase
D007863 Lecithin Cholesterol Acyltransferase Deficiency An autosomal recessive disorder of lipoprotein metabolism caused by mutation of LECITHIN CHOLESTEROL ACYLTRANSFERASE gene. It is characterized by low HDL-cholesterol levels, and the triad of CORNEAL OPACITIES; HEMOLYTIC ANEMIA; and PROTEINURIA with renal failure. Dyslipoproteinemic Corneal Dystrophy,Fish-Eye Disease,LCAT Deficiency,LCATA Deficiency,Lecithin:Cholesterol Acyltransferase Deficiency,Norum Disease,alpha-LCAT Deficiency,alpha-Lecithin-Cholesterol Acyltransferase Deficiency,alpha-Lecithin:Cholesterol Acyltransferase Deficiency,Acyltransferase Deficiency, Lecithin:Cholesterol,Corneal Dystrophy, Dyslipoproteinemic,Deficiency, LCAT,Deficiency, alpha-LCAT,Fish Eye Disease,LCATA Deficiencies,alpha LCAT Deficiency
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002788 Cholesterol Esters Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. Cholesterol Ester,Cholesteryl Ester,Cholesteryl Esters,Ester, Cholesterol,Ester, Cholesteryl,Esters, Cholesterol,Esters, Cholesteryl
D004587 Electrophoresis, Agar Gel Electrophoresis in which agar or agarose gel is used as the diffusion medium. Electrophoresis, Agarose Gel,Agar Gel Electrophoresis,Agarose Gel Electrophoresis,Gel Electrophoresis, Agar,Gel Electrophoresis, Agarose
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004951 Esterification The process of converting an acid into an alkyl or aryl derivative. Most frequently the process consists of the reaction of an acid with an alcohol in the presence of a trace of mineral acid as catalyst or the reaction of an acyl chloride with an alcohol. Esterification can also be accomplished by enzymatic processes. Esterifications

Related Publications

T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
April 1995, Atherosclerosis,
T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
January 1980, Annals of the New York Academy of Sciences,
T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
January 1974, Scandinavian journal of clinical and laboratory investigation. Supplementum,
T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
June 1986, Scandinavian journal of clinical and laboratory investigation,
T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
January 1988, Metabolism: clinical and experimental,
T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
July 1980, Journal of lipid research,
T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
August 1983, Biochimica et biophysica acta,
T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
January 1974, Scandinavian journal of clinical and laboratory investigation. Supplementum,
T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
December 1987, Scandinavian journal of clinical and laboratory investigation,
T Ohta, and S Hattori, and R Nakamura, and S Horiuchi, and J Frohlich, and K Takata, and Y Ikeda, and Y Saito, and I Matsuda
August 2014, Arteriosclerosis, thrombosis, and vascular biology,
Copied contents to your clipboard!